Clinical syndromes: Parkinsonian gait
Identifieur interne : 001073 ( Istex/Corpus ); précédent : 001072; suivant : 001074Clinical syndromes: Parkinsonian gait
Auteurs : Georg Ebersbach ; Caroline Moreau ; Florin Gandor ; Luc Defebvre ; David DevosSource :
- Movement Disorders [ 0885-3185 ] ; 2013-09-15.
Abstract
Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society
Url:
DOI: 10.1002/mds.25675
Links to Exploration step
ISTEX:23B45F61265310D0C20D1ACE60E291C8BD859ADDLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical syndromes: Parkinsonian gait</title><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name><affiliation><mods:affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Gandor, Florin" sort="Gandor, Florin" uniqKey="Gandor F" first="Florin" last="Gandor">Florin Gandor</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: gandor@parkinson-beelitz.de</mods:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><mods:affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Devos, David" sort="Devos, David" uniqKey="Devos D" first="David" last="Devos">David Devos</name><affiliation><mods:affiliation>Pharmacologie Médicale, CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France, Lille, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:23B45F61265310D0C20D1ACE60E291C8BD859ADD</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1002/mds.25675</idno><idno type="url">https://api.istex.fr/document/23B45F61265310D0C20D1ACE60E291C8BD859ADD/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001073</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001073</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical syndromes: Parkinsonian gait</title><author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation></author><author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name><affiliation><mods:affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Gandor, Florin" sort="Gandor, Florin" uniqKey="Gandor F" first="Florin" last="Gandor">Florin Gandor</name><affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: gandor@parkinson-beelitz.de</mods:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><mods:affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Devos, David" sort="Devos, David" uniqKey="Devos D" first="David" last="Devos">David Devos</name><affiliation><mods:affiliation>Pharmacologie Médicale, CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France, Lille, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-09-15">2013-09-15</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1552">1552</biblScope><biblScope unit="page" to="1559">1559</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">23B45F61265310D0C20D1ACE60E291C8BD859ADD</idno><idno type="DOI">10.1002/mds.25675</idno><idno type="ArticleID">MDS25675</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Georg Ebersbach MD</name><affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string></affiliations></json:item><json:item><name>Caroline Moreau MD, PhD</name><affiliations><json:string>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</json:string></affiliations></json:item><json:item><name>Florin Gandor MD</name><affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string><json:string>E-mail: gandor@parkinson-beelitz.de</json:string></affiliations></json:item><json:item><name>Luc Defebvre MD, PhD</name><affiliations><json:string>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</json:string></affiliations></json:item><json:item><name>David Devos MD, PhD</name><affiliations><json:string>Pharmacologie Médicale, CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France, Lille, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>gait</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>falls</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>atypical Parkinsonism</value></json:item></subject><articleId><json:string>MDS25675</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society</abstract><qualityIndicators><score>6.404</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 809.972 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>813</abstractCharCount><pdfWordCount>5164</pdfWordCount><pdfCharCount>35206</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>117</abstractWordCount></qualityIndicators><title>Clinical syndromes: Parkinsonian gait</title><refBibs><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>M Sojer</name></json:item><json:item><name>J Müller</name></json:item></author><host><volume>15</volume><pages><last>1147</last><first>1145</first></pages><author></author><title>Mov Disord</title></host><title>Sociocultural differences in gait</title></json:item><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>M Sojer</name></json:item><json:item><name>F Valldeoriola</name></json:item></author><host><volume>122</volume><pages><last>1355</last><first>1349</first></pages><author></author><title>Brain</title></host><title>Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy</title></json:item><json:item><author><json:item><name>ME Morris</name></json:item><json:item><name>R Iansek</name></json:item><json:item><name>TA Matyas</name></json:item></author><host><volume>117</volume><pages><last>1181</last><first>1169</first></pages><author></author><title>Brain</title></host><title>The pathogenesis of gait hypokinesia in Parkinson's disease</title></json:item><json:item><author><json:item><name>ME Morris</name></json:item><json:item><name>R Iansek</name></json:item><json:item><name>TA Matyas</name></json:item></author><host><volume>119</volume><pages><last>568</last><first>551</first></pages><author></author><title>Brain.</title></host><title>Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms</title></json:item><json:item><author><json:item><name>R Baltadjieva</name></json:item><json:item><name>N Giladi</name></json:item><json:item><name>L Gruendlinger</name></json:item></author><host><volume>24</volume><pages><last>1820</last><first>1815</first></pages><author></author><title>Eur J Neurosci</title></host><title>Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease</title></json:item><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>M Heijmenberg</name></json:item><json:item><name>L Kindermann</name></json:item></author><host><volume>14</volume><pages><last>625</last><first>619</first></pages><author></author><title>Mov Disord</title></host><title>Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease: evidence for impaired locomotor pattern generation in early Parkinson's disease</title></json:item><json:item><author><json:item><name>JM Hausdorff</name></json:item><json:item><name>ME Cudkowicz</name></json:item><json:item><name>R Firtion</name></json:item></author><host><volume>13</volume><pages><last>437</last><first>428</first></pages><author></author><title>Mov Disord</title></host><title>Gait variability and basal ganglia disorders: stride‐to‐stride variations of gait cycle timing in Parkinson's disease and Huntington's disease</title></json:item><json:item><author></author><host><volume>81</volume><pages><last>184</last><first>177</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Cantiniaux S, Vaugoyeau M, Robert D, et al. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?</title></json:item><json:item><author><json:item><name>L Rochester</name></json:item><json:item><name>DJ Burn</name></json:item><json:item><name>G Woods</name></json:item></author><host><volume>24</volume><pages><last>845</last><first>839</first></pages><author></author><title>Mov Disord</title></host><title>Does auditory rhythmical cueing improve gait in people with Parkinson's disease and cognitive impairment? A feasibility study</title></json:item><json:item><author><json:item><name>MA Hely</name></json:item><json:item><name>JGL Morris</name></json:item><json:item><name>WGJ Reid</name></json:item></author><host><volume>20</volume><pages><last>199</last><first>190</first></pages><author></author><title>Mov Disord</title></host><title>Sydney Multicenter Study of Parkinson's disease: non‐L‐dopa‐responsive problems dominate at 15 years</title></json:item><json:item><author><json:item><name>PA Kempster</name></json:item><json:item><name>DR Williams</name></json:item><json:item><name>M Selikhova</name></json:item></author><host><volume>130</volume><pages><last>2128</last><first>2123</first></pages><author></author><title>Brain</title></host><title>Patterns of levodopa response in Parkinson's disease: a clinico‐pathological study</title></json:item><json:item><author><json:item><name>ML Müller</name></json:item><json:item><name>KA Frey</name></json:item><json:item><name>M Petrou</name></json:item></author><host><volume>28</volume><pages><last>301</last><first>296</first></pages><author></author><title>Mov Disord</title></host><title>β‐Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia</title></json:item><json:item><author><json:item><name>BR Bloem</name></json:item><json:item><name>JM Hausdorff</name></json:item><json:item><name>JE Visser</name></json:item></author><host><volume>19</volume><pages><last>884</last><first>871</first></pages><author></author><title>Mov Disord</title></host><title>Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena</title></json:item><json:item><author><json:item><name>N Giladi</name></json:item><json:item><name>A Nieuwboer</name></json:item></author><host><volume>23</volume><pages><last>425</last><first>423</first></pages><issue>Suppl 2</issue><author></author><title>Mov Disord</title></host><title>Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage</title></json:item><json:item><author><json:item><name>JG Nutt</name></json:item><json:item><name>BR Bloem</name></json:item><json:item><name>N Giladi</name></json:item></author><host><volume>10</volume><pages><last>744</last><first>734</first></pages><author></author><title>Lancet Neurol</title></host><title>Freezing of gait: moving forward on a mysterious clinical phenomenon</title></json:item><json:item><author><json:item><name>N Giladi</name></json:item><json:item><name>MP McDermott</name></json:item><json:item><name>S Fahn</name></json:item></author><host><volume>56</volume><pages><last>1721</last><first>1712</first></pages><author></author><title>Neurology</title></host><title>Freezing of gait in PD: prospective assessment in the DATATOP cohort</title></json:item><json:item><author><json:item><name>M Macht</name></json:item><json:item><name>Y Kaussner</name></json:item><json:item><name>JC Möller</name></json:item></author><host><volume>22</volume><pages><last>956</last><first>953</first></pages><author></author><title>Mov Disord</title></host><title>Predictors of freezing in Parkinson's disease: a survey of 6,620 patients</title></json:item><json:item><author><json:item><name>A Ashburn</name></json:item><json:item><name>E Stack</name></json:item><json:item><name>RM Pickering</name></json:item><json:item><name>CD Ward</name></json:item></author><host><volume>47</volume><pages><last>281</last><first>277</first></pages><author></author><title>Gerontology</title></host><title>Predicting fallers in a community‐based sample of people with Parkinson's disease</title></json:item><json:item><author><json:item><name>P Gray</name></json:item><json:item><name>K Hildebrand</name></json:item></author><host><volume>32</volume><pages><last>228</last><first>222</first></pages><author></author><title>J Neurosci Nurs</title></host><title>Fall risk factors in Parkinson's disease</title></json:item><json:item><author><json:item><name>BR Bloem</name></json:item><json:item><name>YA Grimbergen</name></json:item><json:item><name>M Cramer</name></json:item></author><host><volume>248</volume><pages><last>958</last><first>950</first></pages><author></author><title>J Neurol</title></host><title>Prospective assessment of falls in Parkinson's disease</title></json:item><json:item><author><json:item><name>BH Wood</name></json:item><json:item><name>JA Bilclough</name></json:item><json:item><name>A Bowron</name></json:item></author><host><volume>72</volume><pages><last>725</last><first>721</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study</title></json:item><json:item><author><json:item><name>N Giladi</name></json:item><json:item><name>R Kao</name></json:item><json:item><name>S Fahn</name></json:item></author><host><volume>12</volume><pages><last>305</last><first>302</first></pages><author></author><title>Mov Disord</title></host><title>Freezing phenomenon in patients with parkinsonian syndromes</title></json:item><json:item><author><json:item><name>MA Hely</name></json:item><json:item><name>WG Reid</name></json:item><json:item><name>MA Adena</name></json:item><json:item><name>GM Halliday</name></json:item><json:item><name>JG Morris</name></json:item></author><host><volume>23</volume><pages><last>844</last><first>837</first></pages><author></author><title>Mov Disord</title></host><title>The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years</title></json:item><json:item><author><json:item><name>MD Latt</name></json:item><json:item><name>SR Lord</name></json:item><json:item><name>JG Morris</name></json:item><json:item><name>VS Fung</name></json:item></author><host><volume>24</volume><pages><last>1289</last><first>1280</first></pages><author></author><title>Mov Disord</title></host><title>Clinical and physiological assessments for elucidating falls risk in Parkinson's disease</title></json:item><json:item><author><json:item><name>MK Mak</name></json:item><json:item><name>MY Pang</name></json:item></author><host><volume>257</volume><pages><last>1551</last><first>1543</first></pages><author></author><title>J Neurol</title></host><title>Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features</title></json:item><json:item><author><json:item><name>M Amboni</name></json:item><json:item><name>A Cozzolino</name></json:item><json:item><name>K Longo</name></json:item></author><host><volume>23</volume><pages><last>400</last><first>395</first></pages><author></author><title>Mov Disord</title></host><title>Freezing of gait and executive functions in patients with Parkinson's disease</title></json:item><json:item><author><json:item><name>SL Naismith</name></json:item><json:item><name>JM Shine</name></json:item><json:item><name>SJG Lewis</name></json:item></author><host><volume>25</volume><pages><last>1004</last><first>1000</first></pages><author></author><title>Mov Disord</title></host><title>The specific contributions of set‐shifting to freezing of gait in Parkinson's disease</title></json:item><json:item><author><json:item><name>N Giladi</name></json:item><json:item><name>JM Hausdorff</name></json:item></author><host><volume>248</volume><pages><last>176</last><first>173</first></pages><author></author><title>J Neurol Sci</title></host><title>The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease</title></json:item><json:item><author><json:item><name>AH Snijders</name></json:item><json:item><name>BPVD Warrenburg</name></json:item><json:item><name>N Giladi</name></json:item><json:item><name>BR Bloem</name></json:item></author><host><volume>6</volume><pages><last>74</last><first>63</first></pages><author></author><title>Lancet Neurol</title></host><title>Neurological gait disorders in elderly people: clinical approach and classification</title></json:item><json:item><author><json:item><name>VS Kostic</name></json:item><json:item><name>F Agosta</name></json:item><json:item><name>M Pievani</name></json:item></author><host><volume>78</volume><pages><last>416</last><first>409</first></pages><author></author><title>Neurology</title></host><title>Pattern of brain tissue loss associated with freezing of gait in Parkinson disease</title></json:item><json:item><author><json:item><name>M Hallett</name></json:item></author><host><volume>23</volume><pages><last>443</last><first>439</first></pages><issue>Suppl 2</issue><author></author><title>Mov Disord</title></host><title>The intrinsic and extrinsic aspects of freezing of gait</title></json:item><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>M Sojer</name></json:item><json:item><name>J Müller</name></json:item></author><host><volume>73</volume><pages><last>165</last><first>162</first></pages><author></author><title>Nervenarzt</title></host><title>[Dysequilibrium in idiopathic Parkinson disease. The effect of cerebrovascular comorbidity]</title></json:item><json:item><author><json:item><name>WF Abdo</name></json:item><json:item><name>GF Borm</name></json:item><json:item><name>M Munneke</name></json:item></author><host><volume>77</volume><pages><last>1369</last><first>1367</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Ten steps to identify atypical parkinsonism</title></json:item><json:item><author><json:item><name>L Rochester</name></json:item><json:item><name>V Hetherington</name></json:item><json:item><name>D Jones</name></json:item></author><host><volume>85</volume><pages><last>1585</last><first>1578</first></pages><author></author><title>Arch Phys Med Rehabil</title></host><title>Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance</title></json:item><json:item><author><json:item><name>MW Cole</name></json:item><json:item><name>W Schneider</name></json:item></author><host><volume>37</volume><pages><last>360</last><first>343</first></pages><author></author><title>Neuroimage</title></host><title>The cognitive control network: Integrated cortical regions with dissociable functions</title></json:item><json:item><author><json:item><name>JM Shine</name></json:item><json:item><name>E Matar</name></json:item><json:item><name>PB Ward</name></json:item></author><host><volume>8</volume><pages><first>52602</first></pages><author></author><title>PLoS One</title></host><title>Differential neural activation patterns in patients with Parkinson's disease and freezing of gait in response to concurrent cognitive and motor load</title></json:item><json:item><author><json:item><name>AH Snijders</name></json:item><json:item><name>I Leunissen</name></json:item><json:item><name>M Bakker</name></json:item></author><host><volume>134</volume><pages><last>72</last><first>59</first></pages><author></author><title>Brain</title></host><title>Gait‐related cerebral alterations in patients with Parkinson's disease with freezing of gait</title></json:item><json:item><author><json:item><name>K Jahn</name></json:item><json:item><name>A Deutschländer</name></json:item><json:item><name>T Stephan</name></json:item></author><host><volume>39</volume><pages><last>792</last><first>786</first></pages><author></author><title>Neuroimage</title></host><title>Imaging human supraspinal locomotor centers in brainstem and cerebellum</title></json:item><json:item><author><json:item><name>C La Fougère</name></json:item><json:item><name>A Zwergal</name></json:item><json:item><name>A Rominger</name></json:item></author><host><volume>50</volume><pages><last>1598</last><first>1589</first></pages><author></author><title>Neuroimage</title></host><title>Real versus imagined locomotion: a [18F]‐FDG PET‐fMRI comparison</title></json:item><json:item><author><json:item><name>A Zwergal</name></json:item><json:item><name>C la Fougère</name></json:item><json:item><name>S Lorenzl</name></json:item></author><host><volume>80</volume><pages><last>641</last><first>634</first></pages><author></author><title>Neurology</title></host><title>Functional disturbance of the locomotor network in progressive supranuclear palsy</title></json:item><json:item><author><json:item><name>A Tessitore</name></json:item><json:item><name>M Amboni</name></json:item><json:item><name>G Cirillo</name></json:item></author><host><volume>33</volume><pages><last>1809</last><first>1804</first></pages><author></author><title>AJNR Am J Neuroradiol</title></host><title>Regional gray matter atrophy in patients with Parkinson disease and freezing of gait</title></json:item><json:item><author><json:item><name>QJ Almeida</name></json:item><json:item><name>CA Lebold</name></json:item></author><host><volume>81</volume><pages><last>518</last><first>513</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment?</title></json:item><json:item><author><json:item><name>RG Cohen</name></json:item><json:item><name>A Chao</name></json:item><json:item><name>JG Nutt</name></json:item></author><host><volume>49</volume><pages><last>3988</last><first>3981</first></pages><author></author><title>Neuropsychologia</title></host><title>Freezing of gait is associated with a mismatch between motor imagery and motor execution in narrow doorways, not with failure to judge doorway passability</title></json:item><json:item><author><json:item><name>A Berardelli</name></json:item><json:item><name>GK Wenning</name></json:item><json:item><name>A Antonini</name></json:item></author><host><volume>20</volume><pages><last>34</last><first>16</first></pages><author></author><title>Eur J Neurol</title></host><title>EFNS/MDS‐ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease</title></json:item><json:item><author><json:item><name>IG McKeith</name></json:item><json:item><name>D Dickson</name></json:item><json:item><name>J Lowe</name></json:item></author><host><volume>65</volume><pages><last>1872</last><first>1863</first></pages><author></author><title>Neurology</title></host><title>Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium</title></json:item><json:item><author><json:item><name>GK Wenning</name></json:item><json:item><name>Y Ben Shlomo</name></json:item><json:item><name>M Magalhães</name></json:item></author><host><volume>117</volume><pages><last>845</last><first>835</first></pages><author></author><title>Brain</title></host><title>Clinical features and natural history of multiple system atrophy. An analysis of 100 cases</title></json:item><json:item><author><json:item><name>S Gilman</name></json:item><json:item><name>GK Wenning</name></json:item><json:item><name>P Low</name></json:item></author><host><volume>71</volume><pages><last>676</last><first>670</first></pages><author></author><title>Neurology</title></host><title>Second consensus statement on the diagnosis of multiple system atrophy</title></json:item><json:item><author><json:item><name>U Nath</name></json:item><json:item><name>Y Ben‐Shlomo</name></json:item><json:item><name>RG Thomson</name></json:item></author><host><volume>60</volume><pages><last>916</last><first>910</first></pages><author></author><title>Neurology</title></host><title>Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study</title></json:item><json:item><author><json:item><name>DR Williams</name></json:item><json:item><name>JL Holton</name></json:item><json:item><name>K Strand</name></json:item></author><host><volume>22</volume><pages><last>2241</last><first>2235</first></pages><author></author><title>Mov Disord</title></host><title>Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy</title></json:item><json:item><author><json:item><name>MJ Armstrong</name></json:item><json:item><name>I Litvan</name></json:item><json:item><name>A Lang</name></json:item></author><host><volume>80</volume><pages><last>503</last><first>496</first></pages><author></author><title>Neurology</title></host><title>Criteria for the diagnosis of corticobasal degeneration</title></json:item><json:item><author><json:item><name>J Winikates</name></json:item><json:item><name>J Jankovic</name></json:item></author><host><volume>56</volume><pages><last>102</last><first>98</first></pages><author></author><title>Arch Neurol</title></host><title>Clinical correlates of vascular parkinsonism</title></json:item><json:item><author><json:item><name>H Stolze</name></json:item><json:item><name>JP Kuhtz‐Buschbeck</name></json:item><json:item><name>H Drücke</name></json:item></author><host><volume>70</volume><pages><last>297</last><first>289</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease</title></json:item><json:item><author><json:item><name>GK Wenning</name></json:item><json:item><name>G Ebersbach</name></json:item><json:item><name>M Verny</name></json:item></author><host><volume>14</volume><pages><last>950</last><first>947</first></pages><author></author><title>Mov Disord</title></host><title>Progression of falls in postmortem‐confirmed parkinsonian disorders</title></json:item><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>M Gunkel</name></json:item></author><host><volume>26</volume><pages><last>246</last><first>241</first></pages><author></author><title>Mov Disord</title></host><title>Posturography reflects clinical imbalance in Parkinson's disease</title></json:item><json:item><author><json:item><name>S Fahn</name></json:item></author><host><volume>252</volume><pages><last>42</last><first>37</first></pages><issue>Suppl</issue><author></author><title>J Neurol</title></host><title>Does levodopa slow or hasten the rate of progression of Parkinson's disease?</title></json:item><json:item><author><json:item><name>AJ Espay</name></json:item><json:item><name>A Fasano</name></json:item><json:item><name>BFL van Nuenen</name></json:item></author><host><volume>78</volume><pages><last>457</last><first>454</first></pages><author></author><title>Neurology</title></host><title>“On” state freezing of gait in Parkinson disease: a paradoxical levodopa‐induced complication</title></json:item><json:item><author><json:item><name>C Moreau</name></json:item><json:item><name>A Delval</name></json:item><json:item><name>L Defebvre</name></json:item></author><host><volume>11</volume><pages><last>596</last><first>589</first></pages><author></author><title>Lancet Neurol</title></host><title>Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo‐controlled trial</title></json:item><json:item><author><json:item><name>JG Nutt</name></json:item><json:item><name>JH Carter</name></json:item><json:item><name>GJ Sexton</name></json:item></author><host><volume>55</volume><pages><last>773</last><first>766</first></pages><author></author><title>Ann Neurol</title></host><title>The dopamine transporter: importance in Parkinson's disease</title></json:item><json:item><author><json:item><name>P Pollak</name></json:item><json:item><name>Y Dobronesky</name></json:item><json:item><name>T Prohorov</name></json:item></author><host><volume>72</volume><pages><last>148</last><first>145</first></pages><author></author><title>J Neural Transm Suppl</title></host><title>Low doses methylphenidate improves freezing in advanced Parkinson's disease during off‐state</title></json:item><json:item><author><json:item><name>D Devos</name></json:item><json:item><name>P Krystkowiak</name></json:item><json:item><name>F Clement</name></json:item></author><host><volume>78</volume><pages><last>475</last><first>470</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Improvement of gait by chronic high doses of methylphenidate in patients with advanced Parkinson's disease</title></json:item><json:item><author><json:item><name>E Auriel</name></json:item><json:item><name>JM Haussdorff</name></json:item><json:item><name>N Giladi</name></json:item></author><host><volume>32</volume><pages><last>81</last><first>75</first></pages><author></author><title>Clin Neuropharmacol</title></host><title>Methylphenidate for the treatment of Parkinson's disease and other neurological disorders</title></json:item><json:item><author><json:item><name>AJ Espay</name></json:item><json:item><name>AK Dwivedi</name></json:item><json:item><name>L Payne</name></json:item></author><host><volume>76</volume><pages><last>1262</last><first>1256</first></pages><author></author><title>Neurology</title></host><title>Methylphenidate for gait impairment in Parkinson's disease: a randomized clinical trial</title></json:item><json:item><author><json:item><name>JG Nutt</name></json:item><json:item><name>JH Carter</name></json:item><json:item><name>NE Carlson</name></json:item></author><host><volume>64</volume><pages><last>323</last><first>319</first></pages><author></author><title>Arch Neurol</title></host><title>Effects of methylphenidate on response to oral levodopa; a double blind‐clinical trial</title></json:item><json:item><author><json:item><name>C Moreau</name></json:item><json:item><name>A Delval</name></json:item><json:item><name>V Tiffreau</name></json:item></author><host><volume>84</volume><pages><last>555</last><first>552</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Memantine for axial signs in Parkinson's disease: a randomised, double‐blind, placebo‐controlled pilot study</title></json:item><json:item><author><json:item><name>KA Chung</name></json:item><json:item><name>BM Lobb</name></json:item><json:item><name>JG Nutt</name></json:item></author><host><volume>75</volume><pages><last>1269</last><first>1263</first></pages><author></author><title>Neurology</title></host><title>Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease</title></json:item><json:item><author><json:item><name>G Deuschl</name></json:item><json:item><name>C Schade‐Brittinger</name></json:item><json:item><name>P Krack</name></json:item></author><host><volume>355</volume><pages><last>908</last><first>896</first></pages><author></author><title>N Engl J Med</title></host><title>A randomized trial of deep‐brain stimulation for Parkinson's disease</title></json:item><json:item><author><json:item><name>M Zibetti</name></json:item><json:item><name>A Merola</name></json:item><json:item><name>L Rizzi</name></json:item></author><host><volume>26</volume><pages><last>2334</last><first>2327</first></pages><author></author><title>Mov Disord</title></host><title>Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease</title></json:item><json:item><author><json:item><name>WM Schuepbach</name></json:item><json:item><name>J Rau</name></json:item><json:item><name>K Knudsen</name></json:item><json:item><name> </name></json:item></author><host><volume>368</volume><pages><last>622</last><first>610</first></pages><author></author><title>N Engl J Med</title></host><title>Neurostimulation for Parkinson's disease with early motor complications</title></json:item><json:item><author><json:item><name>C Moreau</name></json:item><json:item><name>L Defebvre</name></json:item><json:item><name>A Destée</name></json:item></author><host><volume>71</volume><pages><last>84</last><first>80</first></pages><author></author><title>Neurology</title></host><title>STN‐DBS frequency effects on freezing of gait in advanced Parkinson disease</title></json:item><json:item><author><json:item><name>L Niu</name></json:item><json:item><name>L‐Y Ji</name></json:item><json:item><name>J‐M Li</name></json:item></author><host><volume>40</volume><pages><last>1113</last><first>1108</first></pages><author></author><title>J Int Med Res</title></host><title>Effect of bilateral deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease</title></json:item><json:item><author><json:item><name>MC Rodriguez‐Oroz</name></json:item><json:item><name>JA Obeso</name></json:item><json:item><name>AE Lang</name></json:item></author><host><volume>128</volume><pages><last>2249</last><first>2240</first></pages><author></author><title>Brain</title></host><title>Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow‐up</title></json:item><json:item><author><json:item><name>AMS Muniz</name></json:item><json:item><name>J Nadal</name></json:item><json:item><name>KE Lyons</name></json:item></author><host><volume>35</volume><pages><last>457</last><first>452</first></pages><author></author><title>Gait Posture</title></host><title>Long‐term evaluation of gait initiation in six Parkinson's disease patients with bilateral subthalamic stimulation</title></json:item><json:item><author><json:item><name>JD Hilliard</name></json:item><json:item><name>RC Frysinger</name></json:item><json:item><name>WJ Elias</name></json:item></author><host><volume>89</volume><pages><last>364</last><first>357</first></pages><author></author><title>Stereotact Funct Neurosurg</title></host><title>Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson's disease</title></json:item><json:item><author><json:item><name>T Xie</name></json:item><json:item><name>UJ Kang</name></json:item><json:item><name>P Warnke</name></json:item></author><host><volume>83</volume><pages><last>1017</last><first>1015</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease</title></json:item><json:item><author><json:item><name>A Nieuwboer</name></json:item><json:item><name>G Kwakkel</name></json:item><json:item><name>L Rochester</name></json:item></author><host><volume>78</volume><pages><last>140</last><first>134</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Cueing training in the home improves gait‐related mobility in Parkinson's disease: the RESCUE trial</title></json:item><json:item><author><json:item><name>M Jöbges</name></json:item><json:item><name>G Heuschkel</name></json:item><json:item><name>C Pretzel</name></json:item></author><host><volume>75</volume><pages><last>1687</last><first>1682</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease</title></json:item><json:item><author><json:item><name>G Ebersbach</name></json:item><json:item><name>A Ebersbach</name></json:item><json:item><name>D Edler</name></json:item></author><host><volume>25</volume><pages><last>1908</last><first>1902</first></pages><author></author><title>Mov Disord</title></host><title>Comparing exercise in Parkinson's disease—the Berlin LSVT®BIG study</title></json:item><json:item><author><json:item><name>F Li</name></json:item><json:item><name>P Harmer</name></json:item><json:item><name>K Fitzgerald</name></json:item></author><host><volume>366</volume><pages><last>519</last><first>511</first></pages><author></author><title>N Engl J Med</title></host><title>Tai chi and postural stability in patients with Parkinson's disease</title></json:item><json:item><author><json:item><name>VA Goodwin</name></json:item><json:item><name>SH Richards</name></json:item><json:item><name>W Henley</name></json:item></author><host><volume>82</volume><pages><last>1238</last><first>1232</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>An exercise intervention to prevent falls in people with Parkinson's disease: a pragmatic randomised controlled trial</title></json:item><json:item><author><json:item><name>K Fukada</name></json:item><json:item><name>T Endo</name></json:item><json:item><name>M Yokoe</name></json:item></author><host><volume>80</volume><pages><last>212</last><first>209</first></pages><author></author><title>Med Hypotheses</title></host><title>L‐threo‐3,4‐dihydroxyphenylserine (L‐DOPS) co‐administered with entacapone improves freezing of gait in Parkinson's disease</title></json:item><json:item><author><json:item><name>P Mazzone</name></json:item><json:item><name>A Lozano</name></json:item><json:item><name>P Stanzione</name></json:item></author><host><volume>16</volume><pages><last>1881</last><first>1877</first></pages><author></author><title>Neuroreport</title></host><title>Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease</title></json:item><json:item><author><json:item><name>P Plaha</name></json:item><json:item><name>SS Gill</name></json:item></author><host><volume>16</volume><pages><last>1887</last><first>1883</first></pages><author></author><title>Neuroreport</title></host><title>Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease</title></json:item><json:item><author><json:item><name>A Stefani</name></json:item><json:item><name>AM Lozano</name></json:item><json:item><name>A Peppe</name></json:item></author><host><volume>130</volume><pages><last>1607</last><first>1596</first></pages><author></author><title>Brain</title></host><title>Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease</title></json:item><json:item><author><json:item><name>E Moro</name></json:item><json:item><name>C Hamani</name></json:item><json:item><name>Y‐Y Poon</name></json:item></author><host><volume>133</volume><pages><last>224</last><first>215</first></pages><author></author><title>Brain</title></host><title>Unilateral pedunculopontine stimulation improves falls in Parkinson's disease</title></json:item><json:item><author><json:item><name>MU Ferraye</name></json:item><json:item><name>B Debû</name></json:item><json:item><name>V Fraix</name></json:item></author><host><volume>133</volume><pages><last>214</last><first>205</first></pages><author></author><title>Brain</title></host><title>Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease</title></json:item><json:item><author><json:item><name>BE Fisher</name></json:item><json:item><name>AD Wu</name></json:item><json:item><name>GJ Salem</name></json:item></author><host><volume>89</volume><pages><last>1229</last><first>1221</first></pages><author></author><title>Arch Phys Med Rehabil</title></host><title>The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease</title></json:item><json:item><author><json:item><name>MA Hirsch</name></json:item><json:item><name>BG Farley</name></json:item></author><host><volume>45</volume><pages><last>229</last><first>215</first></pages><author></author><title>Eur J Phys Rehabil Med</title></host><title>Exercise and neuroplasticity in persons living with Parkinson's disease</title></json:item><json:item><author><json:item><name>GM Petzinger</name></json:item><json:item><name>BE Fisher</name></json:item><json:item><name>J‐E van Leeuwen</name></json:item></author><host><volume>25</volume><pages><last>145</last><first>141</first></pages><issue>Suppl 1</issue><author></author><title>Mov Disord</title></host><title>Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease</title></json:item><json:item><author><json:item><name>JA Kleim</name></json:item><json:item><name>TA Jones</name></json:item><json:item><name>T Schallert</name></json:item></author><host><volume>28</volume><pages><last>1769</last><first>1757</first></pages><author></author><title>Neurochem Res</title></host><title>Motor enrichment and the induction of plasticity before or after brain injury</title></json:item><json:item><author><json:item><name>JA Kleim</name></json:item><json:item><name>TA Jones</name></json:item></author><host><volume>51</volume><pages><last>239</last><first>225</first></pages><author></author><title>J Speech Lang Hear Res</title></host><title>Principles of experience‐dependent neural plasticity: implications for rehabilitation after brain damage</title></json:item><json:item><author><json:item><name>JE Ahlskog</name></json:item></author><host><volume>77</volume><pages><last>294</last><first>288</first></pages><author></author><title>Neurology</title></host><title>Does vigorous exercise have a neuroprotective effect in Parkinson disease?</title></json:item></refBibs><genre><json:string>review-article</json:string></genre><host><volume>28</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>8</total><last>1559</last><first>1552</first></pages><issn><json:string>0885-3185</json:string></issn><issue>11</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>clinical neurology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>neurology & neurosurgery</json:string></scienceMetrix></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1002/mds.25675</json:string></doi><id>23B45F61265310D0C20D1ACE60E291C8BD859ADD</id><score>0.24248123</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/23B45F61265310D0C20D1ACE60E291C8BD859ADD/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/23B45F61265310D0C20D1ACE60E291C8BD859ADD/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/23B45F61265310D0C20D1ACE60E291C8BD859ADD/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Clinical syndromes: Parkinsonian gait</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><availability><p>© 2013 Movement Disorder Society© 2013 Movement Disorder Society</p></availability><date>2013-08-31</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Clinical syndromes: Parkinsonian gait</title><author xml:id="author-1"><persName><forename type="first">Georg</forename><surname>Ebersbach</surname></persName><roleName type="degree">MD</roleName><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation></author><author xml:id="author-2"><persName><forename type="first">Caroline</forename><surname>Moreau</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</affiliation></author><author xml:id="author-3"><persName><forename type="first">Florin</forename><surname>Gandor</surname></persName><roleName type="degree">MD</roleName><email>gandor@parkinson-beelitz.de</email><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation></author><author xml:id="author-4"><persName><forename type="first">Luc</forename><surname>Defebvre</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</affiliation></author><author xml:id="author-5"><persName><forename type="first">David</forename><surname>Devos</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Pharmacologie Médicale, CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France, Lille, France</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-09-15"></date><biblScope unit="volume">28</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1552">1552</biblScope><biblScope unit="page" to="1559">1559</biblScope></imprint></monogr><idno type="istex">23B45F61265310D0C20D1ACE60E291C8BD859ADD</idno><idno type="DOI">10.1002/mds.25675</idno><idno type="ArticleID">MDS25675</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2013-08-31</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society</p></abstract><textClass><keywords scheme="keyword"><list><head>keywords</head><item><term>gait</term></item><item><term>Parkinson's disease</term></item><item><term>falls</term></item><item><term>atypical Parkinsonism</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2013-04-03">Received</change><change when="2013-08-16">Registration</change><change when="2013-08-31">Created</change><change when="2013-09-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/23B45F61265310D0C20D1ACE60E291C8BD859ADD/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="mds25675"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="110"><doi>10.1002/mds.v28.11</doi><titleGroup><title type="specialIssueTitle">Gait and Balance in Movement Disorders</title></titleGroup><copyright ownership="thirdParty">© 2013 Movement Disorder Society</copyright><numberingGroup><numbering type="journalVolume" number="28">28</numbering><numbering type="journalIssue">11</numbering></numberingGroup><coverDate startDate="2013-09-15">15 September 2013</coverDate></publicationMeta><publicationMeta level="unit" position="100" type="reviewArticle" status="forIssue"><doi>10.1002/mds.25675</doi><idGroup><id type="unit" value="MDS25675"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">© 2013 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2013-04-03"></event><event type="manuscriptRevised" date="2013-08-09"></event><event type="manuscriptAccepted" date="2013-08-16"></event><event type="xmlCreated" agent="Cenveo Publisher Services" date="2013-08-31"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.2.6 mode:FullText" date="2013-10-21"></event><event type="publishedOnlineFinalForm" date="2013-10-16"></event><event type="firstOnline" date="2013-10-16"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-02"></event></eventGroup><numberingGroup><numbering type="pageFirst">1552</numbering><numbering type="pageLast">1559</numbering></numberingGroup><correspondenceTo><b>Correspondence to</b>: Dr. Florin Gandor, Fachkrankenhaus für Bewegungsstörungen/Parkinson, Paracelsusring 6a, 14547 Beelitz‐Heilstätten, Germany; <email>gandor@parkinson-beelitz.de</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS25675.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Clinical syndromes: Parkinsonian gait</title><title type="short">Gait in Parkinson's Disease</title><title type="shortAuthors">Ebersbach et al.</title></titleGroup><creators><creator affiliationRef="#mds25675-aff-0001" creatorRole="author" xml:id="mds25675-cr-0001"><personName><givenNames>Georg</givenNames> <familyName>Ebersbach</familyName><degrees>MD</degrees></personName></creator><creator affiliationRef="#mds25675-aff-0002" creatorRole="author" xml:id="mds25675-cr-0002"><personName><givenNames>Caroline</givenNames> <familyName>Moreau</familyName><degrees>MD, PhD</degrees></personName></creator><creator affiliationRef="#mds25675-aff-0001" corresponding="yes" creatorRole="author" xml:id="mds25675-cr-0003"><personName><givenNames>Florin</givenNames> <familyName>Gandor</familyName><degrees>MD</degrees></personName></creator><creator affiliationRef="#mds25675-aff-0002" creatorRole="author" xml:id="mds25675-cr-0004"><personName><givenNames>Luc</givenNames> <familyName>Defebvre</familyName><degrees>MD, PhD</degrees></personName></creator><creator affiliationRef="#mds25675-aff-0003" creatorRole="author" xml:id="mds25675-cr-0005"><personName><givenNames>David</givenNames> <familyName>Devos</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation countryCode="DE" type="organization" xml:id="mds25675-aff-0001"><orgName>Movement Disorders Clinic</orgName><address><city>Beelitz‐Heilstätten</city><country>Germany</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="mds25675-aff-0002"><orgDiv>Service de Neurologie et Pathologie du Mouvement</orgDiv><orgName>Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille</orgName><address><city>Lille</city><country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="mds25675-aff-0003"><orgDiv>Pharmacologie Médicale</orgDiv><orgName>CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France</orgName><address><city>Lille</city><country>France</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="mds25675-kwd-0001">gait</keyword><keyword xml:id="mds25675-kwd-0002">Parkinson's disease</keyword><keyword xml:id="mds25675-kwd-0003">falls</keyword><keyword xml:id="mds25675-kwd-0004">atypical Parkinsonism</keyword></keywordGroup><abstractGroup><abstract type="main"><title type="main">ABSTRACT</title><p>Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="mds25675-note-0001"><p><b>Relevant conflicts of interest/financial disclosures</b>: Nothing to report.</p></note><note xml:id="mds25675-note-0002"><p>Full financial disclosures and author roles may be found in the online version of this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Clinical syndromes: Parkinsonian gait</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Gait in Parkinson's Disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Clinical syndromes: Parkinsonian gait</title></titleInfo><name type="personal"><namePart type="given">Georg</namePart><namePart type="family">Ebersbach</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Caroline</namePart><namePart type="family">Moreau</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Florin</namePart><namePart type="family">Gandor</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation><affiliation>E-mail: gandor@parkinson-beelitz.de</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Luc</namePart><namePart type="family">Defebvre</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur. CHRU, EA 1046/4559, Université Lille, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">David</namePart><namePart type="family">Devos</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Pharmacologie Médicale, CHRU, Faculté de Médecine, EA 1046/4559, Université Lille Nord de France, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2013-09-15</dateIssued><dateCreated encoding="w3cdtf">2013-08-31</dateCreated><dateCaptured encoding="w3cdtf">2013-04-03</dateCaptured><dateValid encoding="w3cdtf">2013-08-16</dateValid><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Disturbances of gait manifest in almost all cases of Parkinson's disease (PD), often leading to loss of mobility and increased mortality. In this review a clinically oriented approach to gait disorders in different stages of PD is presented. In addition, interactions between motor behavior and mental processing will be discussed. Analyzing the clinical features of gait can be helpful to differentiate PD from atypical forms of parkinsonism. Bedside tests to distinguish parkinsonian gait disorders are reviewed. There is still an unmet need to effectively treat complex gait disturbances, which are frequently not responsive to dopamine replacement medication. We thus present current approaches for the management of dopa‐refractory gait disorders. © 2013 International Parkinson and Movement Disorder Society</abstract><subject><genre>keywords</genre><topic>gait</topic><topic>Parkinson's disease</topic><topic>falls</topic><topic>atypical Parkinsonism</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov Disord.</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2013</date><detail type="title"><title>Gait and Balance in Movement Disorders</title></detail><detail type="volume"><caption>vol.</caption><number>28</number></detail><detail type="issue"><caption>no.</caption><number>11</number></detail><extent unit="pages"><start>1552</start><end>1559</end><total>8</total></extent></part></relatedItem><identifier type="istex">23B45F61265310D0C20D1ACE60E291C8BD859ADD</identifier><identifier type="DOI">10.1002/mds.25675</identifier><identifier type="ArticleID">MDS25675</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2013 Movement Disorder Society© 2013 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001073 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001073 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:23B45F61265310D0C20D1ACE60E291C8BD859ADD
|texte= Clinical syndromes: Parkinsonian gait
}}
| This area was generated with Dilib version V0.6.29. |  |